Restriction Spectrum Imaging Differentiates True Tumor Progression From Immune-Mediated Pseudoprogression: Case Report of a Patient With Glioblastoma

Immunotherapy is increasingly used in the treatment of glioblastoma (GBM), with immune checkpoint therapy gaining in popularity given favorable outcomes achieved for other tumors. However, immune-mediated (IM)-pseudoprogression is common, remains poorly characterized, and renders conventional imagin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Oncol
Autors principals: Daghighi, Shadi, Bahrami, Naeim, Tom, William J., Coley, Nicholas, Seibert, Tyler M., Hattangadi-Gluth, Jona A., Piccioni, David E., Dale, Anders M., Farid, Nikdokht, McDonald, Carrie R.
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6997150/
https://ncbi.nlm.nih.gov/pubmed/32047723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00024
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars